Welcome to Dwaey, specifically on Pemirolast Potassium 0.1% Eye prep page.
This medicine contains important and useful components, as it consists of
Pemirolast Potassium 0.1% Eye prep is available in the market in concentration.
Pemirolast Potassium 0.1% Eye prep
Before using pemirolast potassium 0.1% eye preparation, it is essential for patients to consult their healthcare provider to ensure the medication is suitable for their condition. Key precautions include:
- Allergic Reactions: Pemirolast potassium should be used with caution in patients with a history of hypersensitivity to pemirolast, any component of the formulation, or other mast cell stabilizers.
- Contact Lens Use: Patients who wear contact lenses should remove them before applying pemirolast potassium eye drops, as it contains preservatives (benzalkonium chloride) that may be absorbed by the lenses and cause irritation. It is advised to wait at least 15 minutes after applying the medication before reinserting contact lenses.
- Eye Conditions: If the patient has a history of eye infections or other eye disorders (e.g., glaucoma, keratitis), the use of pemirolast potassium should be carefully monitored, as it may exacerbate certain conditions.
- Pregnancy and Breastfeeding: There are no well-controlled studies on the use of pemirolast potassium during pregnancy or breastfeeding. Therefore, it is recommended to use the drug only if the potential benefit justifies the potential risk to the fetus or infant. Consult a healthcare provider before use.
Pemirolast potassium 0.1% eye preparation is primarily indicated for:
- Allergic Conjunctivitis: It is used to prevent and treat symptoms associated with allergic conjunctivitis, such as itching, redness, and inflammation of the eyes. It works by stabilizing mast cells and preventing the release of histamine and other inflammatory mediators involved in allergic reactions.
- Allergic Eye Inflammation: Pemirolast potassium is used to reduce inflammation and manage discomfort associated with allergic eye conditions, especially during allergy seasons when symptoms tend to worsen.
Pemirolast potassium 0.1% eye drops should not be used in the following conditions:
- Hypersensitivity: Contraindicated in patients with known hypersensitivity or allergic reactions to pemirolast potassium or any of its ingredients.
- Severe Eye Infections: It should not be used in the presence of bacterial, viral, or fungal eye infections due to the potential for exacerbating the condition or causing secondary infections.
- Children under 3 years old: Safety and efficacy have not been established in children younger than 3 years of age, so it is contraindicated in this age group.
Common and serious side effects of pemirolast potassium 0.1% eye drops include:
- Common Side Effects:
- Eye irritation, stinging, or burning upon application
- Mild eye redness or discomfort
- Blurred vision or temporary visual disturbances
- Serious Side Effects:
- Allergic Reactions: Rare, but some patients may experience an allergic reaction to pemirolast potassium, leading to symptoms such as swelling, itching, or redness of the eyes, eyelids, or surrounding areas.
- Eye Infection: In rare cases, improper use or contamination of the dropper may result in an eye infection.
- Corneal Changes: Long-term use of mast cell stabilizers like pemirolast may, in rare instances, cause changes to the corneal epithelium or affect wound healing in the eyes.
Patients should notify their healthcare provider if they experience persistent discomfort, vision changes, or signs of an allergic reaction, such as swelling around the eyes.
3
Pemirolast potassium 0.1% works as a mast cell stabilizer, primarily by preventing the release of histamine and other inflammatory mediators from mast cells. Here is how it works:
- Inhibition of Mast Cell Degranulation: By stabilizing the mast cells in the conjunctiva of the eye, pemirolast prevents these cells from releasing histamine and other chemicals that cause the inflammatory symptoms of allergic conjunctivitis, such as itching, redness, and swelling.
- Reduction in Inflammatory Mediators: The reduction in the release of histamine and other mediators helps to minimize the allergic response and inflammation, providing symptomatic relief for conditions like allergic eye inflammation.
- Symptom Management: This stabilization of mast cells can help reduce the severity of allergic symptoms and prevent flare-ups, particularly in response to seasonal allergens or environmental triggers.
Although pemirolast potassium is primarily applied topically to the eyes, certain drug interactions should be considered:
- Other Eye Medications: If the patient is using other eye drops (especially other antihistamines or mast cell stabilizers), these should be spaced out by at least 5 minutes to prevent dilution or interference with the effectiveness of pemirolast potassium.
- Topical Steroids: Caution is advised when using pemirolast potassium in combination with topical corticosteroids for ocular conditions, as it may alter the response to steroid therapy or affect the healing of corneal defects.
- Alcohol: While there is no direct interaction between alcohol and pemirolast potassium, alcohol consumption may exacerbate the side effects of allergic conditions or eye irritation, so it is recommended to avoid excessive alcohol intake.
The recommended adult dose of pemirolast potassium 0.1% eye preparation is as follows:
- Allergic Conjunctivitis: Instill one drop into each affected eye twice daily (morning and evening). The dosage may be adjusted based on the severity of symptoms and the patient's response to the medication.
- If the patient is also using other topical eye medications, it is recommended to space the administration of different eye drops by at least 5 minutes.
The recommended dose for children aged 3 years and older is the same as for adults, typically one drop in each affected eye twice daily. Safety and efficacy in children under 3 years of age have not been established, so pemirolast potassium is contraindicated in this age group.
---
As with any medication, it is essential for patients to consult their healthcare provider prior to starting pemirolast potassium eye drops to ensure it is appropriate for their condition and to address any potential risks, interactions, or contraindications.
Pemirolast potassium is not systemically absorbed in significant amounts, so there is generally no need for renal dose adjustments. However, patients with severe renal impairment should consult a healthcare provider to ensure the safety of the medication in their specific case.
Not available in a medicine form yet